ALPS Speak | Podcast on Psychedelic Science

ALPS (Awareness Lectures in Psychedelic studies)

ALPS Speak (Awareness Lectures in Psychedelic Studies) brings together several outstanding researchers, clinicians and patients working with psychedelic substances. Its purpose is simple and precise: to give space to subjective, scientific and therapeutic experiences, and raise awareness on Psychedelic-Assisted Therapy (PAT). Podcast is both in English and French. More info on http://www.alpsconference.com

  1. Bettina Ferdmann — De la RSE à la conscience : les thérapies psychédéliques en Suisse

    1D AGO

    Bettina Ferdmann — De la RSE à la conscience : les thérapies psychédéliques en Suisse

    InvitéeBettina Ferdmann, co-fondatrice de la Fondation Conscience et Santé Mentale. Coach, entrepreneure et écrivaine, Bettina Ferdmann est l'une des pionnières de la RSE en Suisse. Elle a passé sa carrière à relier sens, impact et transformation — aussi bien individuelle qu'organisationnelle. Elle met aujourd'hui cette expérience au service d'un projet visionnaire : la Fondation Conscience et Santé Mentale, dédiée à favoriser l'accès aux thérapies assistées par psychédéliques en Suisse. Dans cet épisode, nous explorons avec elle : – Le fil qui relie la responsabilité d'une entreprise envers la société et celle d'un individu face à sa propre santé mentale– Une médecine de la relation, où médecins, chercheurs et patients co-créent les soins– Le dialogue entre science et sagesses — hypnose, respiration, méditation, rituels traditionnels– L'éthique d'un soin élargi, fondé sur l'empowerment et la dignité– Sa vision d'un projet pionnier qui veut transformer notre rapport collectif à la conscience, au-delà des institutions Une conversation à la croisée de la transformation intérieure et de la transformation sociale.

    25 min

  2. MAR 21

    The Varieties of Transcendent Experiences

    What actually happens to the self under psychedelics? In this episode, linguist and cognitive scientist PD. Dr. Kurt Stocker introduces a new framework for understanding psychedelic experience—beyond “mystical” or “spiritual” labels. Drawing on placebo-controlled studies with LSD and DMT, he explores how experiences of ego dissolution, transcendence, and interconnectedness are structured, described, and interpreted. We dive into the role of language, the difference between immanent and transcendent states, and a key question: even at the edge of self-loss, is something still there to tell the story? A precise, science-driven look at how psychedelics reshape consciousness and the self—and how we make sense of it.

    46 min
  3. Manoj Doss - Memory Under Psychedelics: Encoding, Learning, and the Risk of Illusion

    FEB 1

    Manoj Doss - Memory Under Psychedelics: Encoding, Learning, and the Risk of Illusion

    What happens to memory under psychedelics? In this episode, cognitive neuropsychopharmacologist Manoj Doss breaks down how psychedelics alter memory formation, stabilization, and retrieval. We explore disrupted hippocampal encoding alongside enhanced cortical learning, fear extinction, and reward adaptation—showing how these compounds reshape cognition rather than simply “expand consciousness.” Drawing on behavioral experiments, neuroimaging, and computational models, Manoj explains what makes 5-HT2A psychedelics unique, and why their effects on memory matter for therapy as well as risk—particularly false insight and memory distortion. A clear, science-driven conversation for clinicians, researchers, and curious minds. Watch Manoj's full talk at the 2025 ALPS Conference here: The Current State of Knowledge on How Psychedelics Impact Memory You can follow Manoj on: LinkedInhttps://x.com/ManojDosshttps://x.com/ManojDoss

    53 min
  4. Rick Doblin - MAPS founder - MDMA-Assisted Therapy for PTSD - Phase 3 Decision by FDA - Alps Conference 2023

    10/29/2023

    Rick Doblin - MAPS founder - MDMA-Assisted Therapy for PTSD - Phase 3 Decision by FDA - Alps Conference 2023

    Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). He founded MAPS in 1986 and is considered the godfather of the current psychedelic renaissance.  Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.  It’s thanks to his MAPS organization that MDMA is currently at phase 3 trial in the US and will be normally approved by the FDA to treat PTSD patients in 2024.  For more info on Rick Doblin :  MAPS Founder and President Twitter X : @RickDoblin TED Talk : the future of psychedelic-assisted psychotherapy This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.  More info on the Alps Conference 2023 - ⁠Website⁠ - ⁠Twitter⁠ - ⁠Facebook⁠ - ⁠Instagram⁠ - ⁠Youtube

    26 min
  5. Michael Mithoefer - Clinical trial testing of MDMA-assisted psychotherapy - Alps Conference 2023

    10/29/2023

    Michael Mithoefer - Clinical trial testing of MDMA-assisted psychotherapy - Alps Conference 2023

    Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC. He and his wife, Annie, completed the first MAPS-sponsored Phase Il clinical trial testing MDMA-assisted psychotherapy for crime-related PTSD, and subsequent studies with military veterans, firefighters and police officers, and a pilot study treating couples. He has been Medical Monitor for a series of Phase 2 trials which produced data that led to FDA breakthrough therapy designation. Since 2012 he and Annie have conducted training for research therapists, and  supervision of therapists in two recent, successful Phase 3 clinical trials.  For more info on Michael Mithoefer :  MAPS : https://maps.org/news/media/michael-mithoefer-m-d-principal-investigator/  LinkedIn : https://www.linkedin.com/in/michael-mithoefer-b15bb53b/  This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.  More info on the Alps Conference 2023 - ⁠Website⁠ - ⁠Twitter⁠ - ⁠Facebook⁠ - ⁠Instagram⁠ - ⁠Youtube

    20 min
  6. Vanja Palmers - Zen Monk - Interview on Meditation and Psychedelics - Alps Conference 2023

    10/29/2023

    Vanja Palmers - Zen Monk - Interview on Meditation and Psychedelics - Alps Conference 2023

    Vanja Palmers was born in Austria and grew up in Switzerland. His career as a student at the University of Zürich and as the founder of a successful business start up came to a sudden halt when he ingested a few micrograms of a certain fungi derivative aka LSD. After a few years of being  a Hippie and a Yogi, he ended up becoming a Zen person, specializing in being nobody special, making effort towards effortless, traceless praxis….  with mediocre success - Felsentor and Puregg (two meditation centers) as well as some animal rights campaigns and institutions have materialized.  For more info on Vanja Palmers:  Descending the Mountain - a tender film exploring psilocybin and the nature of consciousness Felsentor Meditation Center in Switzerland  Puregg - Meditation Center in Austria This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.  More info on the Alps Conference 2023 -⁠ ⁠Website⁠⁠ -⁠ ⁠Twitter⁠⁠ -⁠ ⁠Facebook⁠⁠ -⁠ ⁠Instagram⁠⁠ -⁠ ⁠Youtube

    15 min
  7. Abigail Calder - Interview on understanding negative effects from psychedelics - Alps Conference 2023

    10/29/2023

    Abigail Calder - Interview on understanding negative effects from psychedelics - Alps Conference 2023

    Abigail Calder is a PhD candidate at the University in Fribourg, Switzerland, where she heads a research project on the effects of LSD on neuroplasticity in healthy people. She also conducts research into the adverse effects of psychedelics and their underlying causes, as well as psychedelics’ effects on people’s values and well-being, and she recently joined the ALPS Foundation as its research coordinator. She completed her Master’s degree in neuroscience at the University of Bonn and holds a Bachelor’s in psychology from TU Dresden. For more info on Abigail Calder : ⁠Twitter X : @NeuroCalder  LinkedIn : https://www.linkedin.com/in/abigail-calder-bb68831aa/  Fribourg University : https://www.unifr.ch/med/de/section/staff/all/people/323616/a8832 This interview was recorded during the Alps Conference 2023 on Psychedelic Science in Geneva, Switzerland in October 2023.  More info on the Alps Conference 2023 -⁠ ⁠Website⁠⁠ -⁠ ⁠Twitter⁠⁠ -⁠ ⁠Facebook⁠⁠ -⁠ ⁠Instagram⁠⁠ -⁠ ⁠Youtube⁠

    14 min

  8. 02/20/2023

    Interview with Dr. Ben Sessa on Psychedelic Medicine and the Future of Psychiatry

    This interview was recorded on 16.02.2023 for the ALPS Podcast on Psychedelic Science. More info on the ALPS Foundation - Website - Twitter - Facebook - Instagram - Youtube For over 15 years Dr. Ben Sessa has been at the forefront of psychedelic research in the UK through his affiliations with Imperial College London. He has worked for 30 years with patients in the field of addictions and trauma-related psychiatry. Ben has taken part in many psychedelics-related research projects at Bristol University, Cardiff University and Imperial College London, receiving and/or administering these compounds in legal research settings. He is now the Head of Psychedelic Medicine at Awakn Life Sciences, a company opening twenty high street psychedelic medical clinics throughout Europe, providing psychedelic psychotherapy for a wide range of psychiatric indications. More info on Dr. Sessa : Twitter : https://twitter.com/BenSessa Website : http://www.drsessa.com/ Awakn Life Sciences : https://awaknlifesciences.com/

    30 min
See All (33)

About

ALPS Speak (Awareness Lectures in Psychedelic Studies) brings together several outstanding researchers, clinicians and patients working with psychedelic substances. Its purpose is simple and precise: to give space to subjective, scientific and therapeutic experiences, and raise awareness on Psychedelic-Assisted Therapy (PAT). Podcast is both in English and French. More info on http://www.alpsconference.com

Information

  • Creator
    ALPS (Awareness Lectures in Psychedelic studies)
  • Years Active
    2021 - 2026
  • Episodes
    33
  • Rating
    Clean
  • Copyright
    © ALPS (Awareness Lectures in Psychedelic studies)
  • Show Website
    ALPS Speak | Podcast on Psychedelic Science